Ultima HCG 10000IU

Human Chorionic Gonadotropin is a potent polypeptide hormone present in the bodies of pregnant women. It is primarily used in medical treatment for issues such as cryptorchidism, female infertility, hypogonadism (low testosterone), and weight loss.

Furthermore, many users of anabolic steroids utilize HCG as a supplementary agent either during or after their steroid cycle. When using anabolic steroids, HCG helps counteract the hormonal suppression caused by these substances. After steroid use, it is employed to facilitate a more efficient recovery of the body's natural testosterone production.

One of the main uses of HCG today is in weight loss programs. The HCG diet has gained popularity in western medicine, although its effectiveness is highly debated. The American Medical Association and the American Society of Bariatric Physicians have criticized the HCG diet, claiming that weight loss occurs primarily due to the severe calorie restriction (often limited to 500 calories a day) rather than the hormone itself. Additionally, studies indicate that HCG does not stimulate the thyroid, act as a beta-2 stimulant, suppress appetite, or have thermogenic properties associated with fat burning. Despite this, many doctors report weight loss success on the HCG diet, though critics maintain that the accompanying starvation is not a sustainable or healthy long-term approach. Currently, there's insufficient evidence to assert HCG as the sole reason for any weight loss observed in patients who could achieve similar results from calorie restriction alone. This controversial diet is likely to remain a topic of discussion for years to come.

For anabolic steroid users, the impacts of HCG can be categorized into two areas: use during a steroid cycle (on-cycle use) and use during post-cycle therapy (PCT). Anabolic steroid use typically suppresses natural testosterone production significantly. Once all steroids are ceased, testosterone production may resume, but this process can be gradual. Often, individuals experience low testosterone levels and related symptoms, which can be disruptive and may lead to muscle loss as cortisol becomes dominant in the absence of testosterone. Consequently, most steroid users will adopt a PCT strategy, which can speed up recovery. While HCG alone will not restore levels to normal, it can ensure enough testosterone is present for adequate bodily functions during the recovery process.

Various PCT plans exist, most of which incorporate Selective Estrogen Receptor Modulators (SERMs) like Nolvadex (Tamoxifen Citrate) and/or Clomid (Clomiphene Citrate). Many have discovered that initiating a PCT plan with HCG prior to using SERMs enhances overall recovery. In essence, HCG mimics luteinizing hormone (LH) and prepares the body for the impending SERM therapy, leading to a more efficient recovery.

The second beneficial effect of HCG for steroid users is its use during steroid cycles. Since anabolic steroids can lead to testicular atrophy due to suppressed natural testosterone production, supplementing with HCG can maintain testicular size. While this is largely cosmetic and offers no strategic advantage, it may also ease the recovery process once steroid use ceases. However, a significant risk is that the body can easily develop a dependency on HCG for its LH needs. While the body cannot become dependent on anabolic steroids, it can become dependent on HCG. This dependency is not an issue for low testosterone patients using HCG. However, for those who are not low testosterone patients, careful regulation and monitoring of HCG use during a cycle is crucial to prevent LH dependency. Some steroid users have caused greater harm to their bodies through improper HCG use than they would have experienced from steroid use alone. While on-cycle use may assist in transitioning to recovery, it must be done responsibly. Ultimately, HCG use should be carefully managed, regardless of whether it's used during a cycle or as an initiation for PCT.

For anabolic steroid users, particularly during a steroid cycle, the standard HCG dose is 250 IU every 4-5 days, which provides sufficient levels to achieve desired results without exceeding amounts that could harm natural testosterone production.

Finally, there are two accepted protocols for HCG use during PCT. The first method involves administering 1,500-4,000 IU every 3-4 days for 2-3 weeks, after which SERM therapy should commence. The second, and potentially more effective method, is daily administration of 500-1,000 IU for ten consecutive days, followed by SERM therapy after this phase concludes.

When using HCG during PCT, timing is critical. If your steroid cycle concluded with larger ester-based steroids, begin HCG therapy ten days after the final injection, followed by SERM therapy. Conversely, if the cycle ended with smaller ester-based steroids, initiate HCG therapy three days post last injection and then continue with SERM therapy after HCG treatment ends.